Journal of Pharmacology and Experimental Therapeutics: 338 (1)

July 01, 2011; Volume 338,Issue 1

Highlighted Papers

You have access
MDM2 Knockdown Requires Wild-Type p53 Expression to Inhibit Prostate Cancer Growth
Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;
You have access
Natural Variations in Human Cholinesterase Genes Associated with Cardiovascular Disease
Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;
You have access
Estrogen Receptor Independent Effects of Tamoxifen
Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;
You have access
Tramadol and Abuse Liability in Humans
Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;

Behavioral Pharmacology

You have access
Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor
T. J. Hudzik, C. Maciag, M. A. Smith, R. Caccese, M. R. Pietras, K. H. Bui, M. Coupal, L. Adam, K. Payza, A. Griffin, G. Smagin, D. Song, M. D. B. Swedberg and W. Brown

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 195-204; DOI: https://doi.org/10.1124/jpet.111.179432
You have access
Discriminative Stimulus Effects of Tramadol in Humans
Angela N. Duke, George E. Bigelow, Ryan K. Lanier and Eric C. Strain

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 255-262; DOI: https://doi.org/10.1124/jpet.111.181131

Cardiovascular

You have access
Celecoxib and 2,5-Dimethyl-Celecoxib Prevent Cardiac Remodeling Inhibiting Akt-Mediated Signal Transduction in an Inherited Dilated Cardiomyopathy Mouse Model
Xueli Fan, Fumi Takahashi-Yanaga, Sachio Morimoto, Dong-Yun Zhan, Kazunobu Igawa, Katsuhiko Tomooka and Toshiyuki Sasaguri

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 2-11; DOI: https://doi.org/10.1124/jpet.111.179325
You have access
Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding
Patrick André, Francis DeGuzman, Helena Haberstock-Debic, Scott Mills, Yvonne Pak, Mayuko Inagaki, Anjali Pandey, Stanley Hollenbach, David R. Phillips and Pamela B. Conley

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 22-30; DOI: https://doi.org/10.1124/jpet.110.178574
You have access
Catalase and Superoxide Dismutase Conjugated with Platelet-Endothelial Cell Adhesion Molecule Antibody Distinctly Alleviate Abnormal Endothelial Permeability Caused by Exogenous Reactive Oxygen Species and Vascular Endothelial Growth Factor
Jingyan Han, Vladimir V. Shuvaev and Vladimir R. Muzykantov

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 82-91; DOI: https://doi.org/10.1124/jpet.111.180620
You have access
The Bulky N(6) Substituent of Cabergoline Is Responsible for Agonism of This Drug at 5-Hydroxytryptamine (5-HT)_2A and 5-HT_2B Receptors and Thus Is a Determinant of Valvular Heart Disease
Alexandra Kekewska, Harald Hübner, Peter Gmeiner and Heinz H. Pertz

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 381-391; DOI: https://doi.org/10.1124/jpet.111.181255

Cellular and Molecular

You have access
Regulation of κ-Opioid Receptor Signaling in Peripheral Sensory Neurons In Vitro and In Vivo
Kelly A. Berg, Matthew P. Rowan, Teresa A. Sanchez, Michelle Silva, Amol M. Patwardhan, Stephen B. Milam, Kenneth M. Hargreaves and William P. Clarke

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 92-99; DOI: https://doi.org/10.1124/jpet.110.177493
You have access
Identification and Characterization of INCB9471, an Allosteric Noncompetitive Small-Molecule Antagonist of C-C Chemokine Receptor 5 with Potent Inhibitory Activity against Monocyte Migration and HIV-1 Infection
Niu Shin, Kim Solomon, Naiming Zhou, Kathy He Wang, Vasudha Garlapati, Beth Thomas, Yanlong Li, Maryanne Covington, Frederic Baribaud, Susan Erickson-Viitanen, Phil Czerniak, Nancy Contel, Phillip Liu, Timothy Burn, Gregory Hollis, Swamy Yeleswaram, Kris Vaddi, Chu-Biao Xue, Brian Metcalf, Steve Friedman, Peggy Scherle and Robert Newton

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 228-239; DOI: https://doi.org/10.1124/jpet.111.179531
You have access
The Ligands of Estrogen Receptor α Regulate Cytochrome P4502C9 (CYP2C9) Expression
Jessica Mwinyi, Isa Cavaco, Begum Yurdakok, Souren Mkrtchian and Magnus Ingelman-Sundberg

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 302-309; DOI: https://doi.org/10.1124/jpet.110.175075
You have access
Identification of a High-Affinity Ligand That Exhibits Complete Aryl Hydrocarbon Receptor Antagonism
Kayla J. Smith, Iain A. Murray, Rachel Tanos, John Tellew, Anthony E. Boitano, William H. Bisson, Siva K. Kolluri, Michael P. Cooke and Gary H. Perdew

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 318-327; DOI: https://doi.org/10.1124/jpet.110.178392

Chemotherapy, Antibiotics, and Gene Therapy

You have access
Rapamycin Inhibits Formation of Urethral Stricture in Rabbits
Tie Chong, De-lai Fu, He-cheng Li, Hui-bo Zhang, Peng Zhang, Wei-min Gan and Zi-ming Wang

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 47-52; DOI: https://doi.org/10.1124/jpet.110.178624
You have access
Synergistic Suppression of Prostatic Cancer Cells by Coexpression of Both Murine Double Minute 2 Small Interfering RNA and Wild-Type p53 Gene In Vitro and In Vivo
Kun Ji, Bo Wang, Yue-ting Shao, Ling Zhang, Ya-nan Liu, Chen Shao, Xiao-jie Li, Xin Li, Jia-di Hu, Xue-jian Zhao, De-qi Xu, Yang Li and Lu Cai

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 173-183; DOI: https://doi.org/10.1124/jpet.111.180364

Drug Discovery and Translational Medicine

You have access
A Method to Quantify Illicit Intake of Drugs from Urine: Methamphetamine
Linghui Li, Gantt P. Galloway, Davide Verotta, E. Thomas Everhart, Matthew J. Baggott, Jeremy R. Coyle, Juan C. Lopez and John Mendelson

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 31-36; DOI: https://doi.org/10.1124/jpet.111.179176
You have access
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
Kay Ahn, Sarah E. Smith, Marya B. Liimatta, David Beidler, Nalini Sadagopan, David T. Dudley, Tim Young, Paul Wren, Yanhua Zhang, Steven Swaney, Keri Van Becelaere, Jacqueline L. Blankman, Daniel K. Nomura, Shobha N. Bhattachar, Cory Stiff, Tyzoon K. Nomanbhoy, Eranthie Weerapana, Douglas S. Johnson and Benjamin F. Cravatt

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 114-124; DOI: https://doi.org/10.1124/jpet.111.180257
You have access
ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor, Reduces Tumor Microvascularity and Improves Vascular Wall Integrity in Preclinical Tumor Models
Fang Jiang, Daniel H. Albert, Yanping Luo, Paul Tapang, Ke Zhang, Steven K. Davidsen, Gerard B. Fox, Richard Lesniewski and Evelyn M. McKeegan

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 134-142; DOI: https://doi.org/10.1124/jpet.110.178061
You have access
The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
Stacey J. Sukoff Rizzo, Sarah K. Leonard, Adam Gilbert, Paul Dollings, Deborah L. Smith, Mei-Yi Zhang, Li Di, Brian J. Platt, Sarah Neal, Jason M. Dwyer, Corey N. Bender, Jean Zhang, Tim Lock, Dianne Kowal, Angela Kramer, Andrew Randall, Christine Huselton, Karthick Vishwanathan, Susanna Y. Tse, John Butera, Robert H. Ring, Sharon Rosenzweig-Lipson, Zoë A. Hughes and John Dunlop

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 345-352; DOI: https://doi.org/10.1124/jpet.110.177378

Endocrine and Diabetes

You have access
Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese Mice
Wei Gu, David J. Lloyd, Narumol Chinookswong, Renée Komorowski, Glenn Sivits, Melissa Graham, Katherine A. Winters, Hai Yan, Laszlo G. Boros, Richard A. Lindberg and Murielle M. Véniant

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 70-81; DOI: https://doi.org/10.1124/jpet.111.179986
You have access
Tamoxifen Regulation of Bone Growth and Endocrine Function in the Ovariectomized Rat: Discrimination of Responses Involving Estrogen Receptor α/Estrogen Receptor β, G Protein-Coupled Estrogen Receptor, or Estrogen-Related Receptor γ Using Fulvestrant (ICI 182780)
James M. Fitts, Robert M. Klein and C. Andrew Powers

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 246-254; DOI: https://doi.org/10.1124/jpet.110.173955

Gastrointestinal, Hepatic, Pulmonary, and Renal

You have access
Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice
Andy Wolfe, Ann Thomas, Genea Edwards, Reshma Jaseja, Grace L. Guo and Udayan Apte

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 12-21; DOI: https://doi.org/10.1124/jpet.111.179390
You have access
Pharmacologic Specificity of Nicotinic Receptor-Mediated Relaxation of Muscarinic Receptor Precontracted Human Gastric Clasp and Sling Muscle Fibers within the Gastroesophageal Junction
Alan S. Braverman, Anil K. Vegesna, Larry S. Miller, Mary F. Barbe, Mansoor Tiwana, Kashif Hussain and Michael R. Ruggieri

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 37-46; DOI: https://doi.org/10.1124/jpet.110.177097
You have access
Retinol-Binding Protein 4 and Peroxisome Proliferator-Activated Receptor-γ in Steatotic Liver Transplantation
Araní Casillas-Ramírez, Izabel Alfany-Fernández, Marta Massip-Salcedo, M. Emília Juan, Joana M. Planas, Anna Serafín, Mercè Pallàs, Antoni Rimola, Juan Rodés and Carmen Peralta

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 143-153; DOI: https://doi.org/10.1124/jpet.110.177691
You have access
Comparative Analysis of the Effects of Antimuscarinic Agents on Bladder Functions in Both Nonhuman Primates and Rodents
Hiroshi Nagabukuro, Katherine L. Villa, L. Alexandra Wickham, Alison A. Kulick, Loise Gichuru, Marcie J. Donnelly, Gregory O. Voronin, Tony Pereira, Xinchun Tong, Andrew Nichols, Stephen E. Alves, Gary P. O'Neill, Christopher V. Johnson and Emily J. Hickey

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 220-227; DOI: https://doi.org/10.1124/jpet.111.179747
You have access
Distinct Actions of Endothelin A-Selective Versus Combined Endothelin A/B Receptor Antagonists in Early Diabetic Kidney Disease
Mohamed A. Saleh, Jennifer S. Pollock and David M. Pollock

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 263-270; DOI: https://doi.org/10.1124/jpet.111.178988
You have access
Rho Kinase Inhibition by Fasudil Attenuates Cyclosporine-Induced Kidney Injury
Jeong Woo Park, Cheon Hoon Park, In Jin Kim, Eun Hui Bae, Seong Kwon Ma, Jong Un Lee and Soo Wan Kim

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 271-279; DOI: https://doi.org/10.1124/jpet.111.179457
You have access
JNJ-26070109 [(R)4-Bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: A Novel, Potent, and Selective Cholecystokinin 2 Receptor Antagonist with Good Oral Bioavailability
Magda F. Morton, Terrance D. Barrett, Jamie Freedman, Lina Li, Michele C. Rizzolio, Clodagh E. Prendergast, Xiaodong Wu, Veronica Moreno, Jayashree Pyati, Katherine Figueroa, Laurence Cagnon, Guy Lagaud, Luc Ver Donck, Etienne Ghoos, Brett Allison, Michael H. Rabinowitz and Nigel P. Shankley

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 328-336; DOI: https://doi.org/10.1124/jpet.110.178483
You have access
Rapid, Nongenomic Stimulation of Multidrug Resistance Protein 2 (Mrp2) Activity by Glucocorticoids in Renal Proximal Tubule
Brigitte Prevoo, David S. Miller, Femke M. van de Water, Kimberley E. Wever, Frans G. M. Russel, Gert Flik and Rosalinde Masereeuw

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 362-371; DOI: https://doi.org/10.1124/jpet.111.179689
You have access
Enhanced Sensitivity to Afferent Stimulation and Impact of Overactive Bladder Therapies in the Conscious, Spontaneously Hypertensive Rat
Phani B. Patra and Kevin S. Thorneloe

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 392-399; DOI: https://doi.org/10.1124/jpet.111.180885
You have access
Type 1 Diabetes-Induced Hyper-Responsiveness to 5-Hydroxytryptamine in Rat Pulmonary Arteries via Oxidative Stress and Induction of Cyclooxygenase-2
Jose G. Lopez-Lopez, Javier Moral-Sanz, Giovanna Frazziano, Maria J. Gomez-Villalobos, Laura Moreno, Carmen Menendez, Jorge Flores-Hernandez, Jose A. Lorente, Angel Cogolludo and Francisco Perez-Vizcaino

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 400-407; DOI: https://doi.org/10.1124/jpet.111.179515

Inflammation, Immunopharmacology, and Asthma

You have access
Antiarthritis Effect of a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor in Rat Collagen-Induced Arthritis and Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships between Inhibition of BTK Phosphorylation and Efficacy
Lichuan Liu, Julie Di Paolo, Jim Barbosa, Hong Rong, Karin Reif and Harvey Wong

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 154-163; DOI: https://doi.org/10.1124/jpet.111.181545
You have access
Cinnamyl-3,4-Dihydroxy-α-Cyanocinnamate Is a Potent Inhibitor of 5-Lipoxygenase
Carlo Pergola, Bianca Jazzar, Antonietta Rossi, Ulrike Buehring, Susann Luderer, Friederike Dehm, Hinnak Northoff, Lidia Sautebin and Oliver Werz

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 205-213; DOI: https://doi.org/10.1124/jpet.111.180794
You have access
Pharmacology of AM211, a Potent and Selective Prostaglandin D₂ Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation
Gretchen Bain, Daniel S. Lorrain, Karin J. Stebbins, Alex R. Broadhead, Angelina M. Santini, Pat Prodanovich, Janice Darlington, Christopher D. King, Catherine Lee, Christopher Baccei, Brian Stearns, Yen Troung, John H. Hutchinson, Peppi Prasit and Jilly F. Evans

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 290-301; DOI: https://doi.org/10.1124/jpet.111.180430

Metabolism, Transport, and Pharmacogenomics

You have access
Naturally Occurring Variations in the Human Cholinesterase Genes: Heritability and Association with Cardiovascular and Metabolic Traits
Anne M. Valle, Zoran Radić, Brinda K. Rana, Vafa Mahboubi, Jennifer Wessel, Pei-an Betty Shih, Fangwen Rao, Daniel T. O'Connor and Palmer Taylor

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 125-133; DOI: https://doi.org/10.1124/jpet.111.180091
You have access
Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences
Melanie Mueller, Amy K. Goodwin, Nancy A. Ator, Una D. McCann and George A. Ricaurte

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 310-317; DOI: https://doi.org/10.1124/jpet.111.180612
You have access
In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
Mark Jean Gnoth, Ulf Buetehorn, Uwe Muenster, Thomas Schwarz and Steffen Sandmann

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 372-380; DOI: https://doi.org/10.1124/jpet.111.180240

Neuropharmacology

You have access
The Efficacy of Sodium Channel Blockers to Prevent Phencyclidine-Induced Cognitive Dysfunction in the Rat: Potential for Novel Treatments for Schizophrenia
Charles H. Large, Silvia Bison, Ilaria Sartori, Kevin D. Read, Alessandro Gozzi, Davide Quarta, Marinella Antolini, Emma Hollands, Catherine H. Gill, Martin J. Gunthorpe, Nagi Idris, Jo C. Neill and Giuseppe S. Alvaro

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 100-113; DOI: https://doi.org/10.1124/jpet.110.178475
You have access
Haloperidol Disrupts Opioid-Antinociceptive Tolerance and Physical Dependence
Cheng Yang, Yan Chen, Lei Tang and Zaijie Jim Wang

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 164-172; DOI: https://doi.org/10.1124/jpet.110.175539
You have access
Selective GABA Transporter Inhibitors Tiagabine and EF1502 Exhibit Mechanistic Differences in Their Ability to Modulate the Ataxia and Anticonvulsant Action of the Extrasynaptic GABA_A Receptor Agonist Gaboxadol
Karsten K. Madsen, Bjarke Ebert, Rasmus P. Clausen, Povl Krogsgaard-Larsen, Arne Schousboe and H. Steve White

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 214-219; DOI: https://doi.org/10.1124/jpet.111.179671
You have access
Amperometric Measurement of Glutamate Release Modulation by Gabapentin and Pregabalin in Rat Neocortical Slices: Role of Voltage-Sensitive Ca²⁺ α₂δ-1 Subunit
Jorge E. Quintero, David J. Dooley, François Pomerleau, Peter Huettl and Greg A. Gerhardt

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 240-245; DOI: https://doi.org/10.1124/jpet.110.178384
You have access
Abuse Liability Profile of Three Substituted Tryptamines
Michael B. Gatch, Michael J. Forster, Aaron Janowsky and Amy J. Eshleman

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 280-289; DOI: https://doi.org/10.1124/jpet.111.179705
You have access
Fasudil and Ozagrel in Combination Show Neuroprotective Effects on Cerebral Infarction after Murine Middle Cerebral Artery Occlusion
Akihiro Koumura, Junya Hamanaka, Koh Kawasaki, Kazuhiro Tsuruma, Masamitsu Shimazawa, Isao Hozumi, Takashi Inuzuka and Hideaki Hara

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 337-344; DOI: https://doi.org/10.1124/jpet.110.177675

Toxicology

You have access
Cerium Oxide Nanoparticles Inhibits Oxidative Stress and Nuclear Factor-κB Activation in H9c2 Cardiomyocytes Exposed to Cigarette Smoke Extract
Jianli Niu, Kangkai Wang and Pappachan E. Kolattukudy

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 53-61; DOI: https://doi.org/10.1124/jpet.111.179978
You have access
Inhibition of Rab1 GTPase and Endoplasmic Reticulum-to-Golgi Trafficking Underlies Statin's Toxicity in Rat Skeletal Myofibers
Kazuho Sakamoto, Ikuo Wada and Junko Kimura

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 62-69; DOI: https://doi.org/10.1124/jpet.111.179762
You have access
Up-Regulation of Extracellular Signal-Regulated Kinase 1/2-Dependent Thymidylate Synthase and Thymidine Phosphorylase Contributes to Cisplatin Resistance in Human Non–Small-Cell Lung Cancer Cells
Jen-Chung Ko, Min-Shao Tsai, Yu-Fan Chiu, Shao-Hsing Weng, Ya-Hsun Kuo and Yun-Wei Lin

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 184-194; DOI: https://doi.org/10.1124/jpet.111.179663
You have access
Metabolism of [D₁₀]Phenanthrene to Tetraols in Smokers for Potential Lung Cancer Susceptibility Assessment: Comparison of Oral and Inhalation Routes of Administration
Yan Zhong, Jing Wang, Steven G. Carmella, J. Bradley Hochalter, Diane Rauch, Andrew Oliver, Joni Jensen, Dorothy K. Hatsukami, Pramod Upadhyaya, Cheryl Zimmerman and Stephen S. Hecht

Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 353-361; DOI: https://doi.org/10.1124/jpet.111.181719

Errata

You have access
Correction to “Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2”
Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 408-409;
You have access
Correction to “N-((1S)-1-{[4-((2S)-2-{[2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part I”
Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 410;

Main menu

User menu

Search

Table of Contents

Highlighted Papers

Behavioral Pharmacology

Cardiovascular

Cellular and Molecular

Chemotherapy, Antibiotics, and Gene Therapy

Drug Discovery and Translational Medicine

Endocrine and Diabetes

Gastrointestinal, Hepatic, Pulmonary, and Renal

Inflammation, Immunopharmacology, and Asthma

Metabolism, Transport, and Pharmacogenomics

Neuropharmacology

Toxicology

Errata

In this issue

Jump to

Navigate

More Information

ASPET's Other Journals